BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30695916)

  • 1. [Research progress of dyskeratosis congenita].
    Wang F; Du YQ; Gong W; Sun CK; Zeng X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Feb; 54(2):130-134. PubMed ID: 30695916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyskeratosis congenita: report of two cases with distinct clinical presentations.
    Demirgüneş FE; Elçin G; Sahin S
    Turk J Pediatr; 2008; 50(6):604-8. PubMed ID: 19227430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.
    Callea M; Martinelli D; Cammarata-Scalisi F; Grimaldi C; Jilani H; Grimaldi P; Willoughby CE; Morabito A
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
    BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dyskeratosis congenita: an update].
    Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
    Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita.
    Savage SA; Alter BP
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):215-31. PubMed ID: 19327580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskeratosis congenita: presentation of cutaneous triad in a sporadic case.
    Sharma RK; Gupta M; Sood S; Gupta A
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in dyskeratosis congenita.
    Nishio N; Kojima S
    Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskeratosis congenita associated with leukoplakia of the tongue.
    Noto Z; Tomihara K; Furukawa K; Noguchi M
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita.
    Kanegane H; Kasahara Y; Okamura J; Hongo T; Tanaka R; Nomura K; Kojima S; Miyawaki T
    Br J Haematol; 2005 May; 129(3):432-4. PubMed ID: 15842668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature.
    Treister N; Lehmann LE; Cherrick I; Guinan EC; Woo SB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Nov; 98(5):566-71. PubMed ID: 15529128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita: oral hyperkeratosis in association with lichenoid reaction.
    Handley TP; Ogden GR
    J Oral Pathol Med; 2006 Sep; 35(8):508-12. PubMed ID: 16918603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis and treatment of dyskeratosis congenita: a review.
    Fernández García MS; Teruya-Feldstein J
    J Blood Med; 2014; 5():157-67. PubMed ID: 25170286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Ballew BJ; Savage SA
    Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.
    Vulliamy T; Marrone A; Goldman F; Dearlove A; Bessler M; Mason PJ; Dokal I
    Nature; 2001 Sep; 413(6854):432-5. PubMed ID: 11574891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Transplant for Management of Hepatic Complications of Dyskeratosis Congenita: A Case Report.
    Alebrahim M; Akateh C; Arnold CA; Benissan-Messan D; Chavez JA; Singh N; Al-Adwan Y; El-Hinnawi A; Michaels A; Black SM
    Exp Clin Transplant; 2022 Jul; 20(7):702-705. PubMed ID: 33272154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita and telomere biology disorders.
    Savage SA
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):637-648. PubMed ID: 36485133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel mutation in DKC1 in dyskeratosis congenita.
    Kurnikova M; Shagina I; Khachatryan L; Schagina O; Maschan M; Shagin D
    Pediatr Blood Cancer; 2009 Jan; 52(1):135-7. PubMed ID: 18802941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and genetic characteristics of a patient with dyskeratosis congenita].
    Li JG; Li Y; Lin ZM; Ma ZH; Li JH; Liu R; Shi XD; Yang Y; Wang TY
    Zhonghua Er Ke Za Zhi; 2009 Nov; 47(11):867-70. PubMed ID: 20079002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.